The Carlyle Group has agreed to acquire up to a 74% stake in India-based animal health care services provider SeQuent Scientific for USD216m. CA Harbor Investments, an entity affiliated with CAP V Mauritius and the Carlyle Group, will acquire a majority stake in SeQuent via private share purchase agreements. The proposed transaction will trigger a mandatory open offer by CA Harbor Investments and CAP V Mauritius for the purchase of up to a further 26% stake of SeQuent from public shareholders. The transaction is expected to close in the third quarter of 2020. Read more